EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
16/06/2026
Voltar para busca
Dado oficial do USPTO
ZEGFROVY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
18/06/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5
Data de depósito
07/06/2022
Data de registro
14/01/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
14/01/2025
Última transação
18/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
04/12/2023
Primeiro uso no comércio
04/12/2023
Código do desenho
3
Tipo de titular
03
Localização do titular
Wuxi City, Jiangsu, CN
Examinador
DELGIZZI, RONALD ERNEST
Unidade examinadora
L70
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the literal element "ZEGFROVY" to the right of a design consisting of two pairs of differing fanciful geometric shapes intended to depict a gene mutation process.
Titulares e representantes
Titulares
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Representantes
He Li
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Acids for pharmaceutical purposes; adjuvants for medical purposes; agricultural fungicide; aluminum acetates for pharmaceutical purposes; amino acids for medical purposes; analgesics; anti-allergic and pain reduction medicines for treatment of illnesses for human purposes; antibioticsunburn and anti-inflammatory ointments for pharmaceutical purposes; antibiotics; antioxidant pills for medical use; antiseptics; astringents for medical purposes; bacterial culture mediums; bacterial poisons; bacterial preparations for medical purposes for researching of human illnesses; bacteriological research preparationpreparations of reports for anti-tumor treatment for medical purposes; balsamic preparations for medical purposes; biological agents for the treatment of cancer; biological preparations for medical purposes for treatment of human illnesses; biological tissue cultures for medical purposes; blood for medical purposes; blood plasma; bouillons for bacteriological cultures; bronchodilating preparations; by-products of the processing of cereals for dietetic or medical purposes; cachets in the nature of capsules for medicinal preparations for the mouth for pharmaceutical purposes; candy for medical purposes; candy for pharmaceutical purpose for treatment of the cough; capsules made of dendrimer-based polymers for medicinal preparations for the mouthfor pharmaceuticals purposes; cellulose esters for pharmaceutical purposes; cellulose ethers for pharmaceutical purposes; chemical preparations as medicines for medical purposesfor anti-tumor treatment; chemical preparations for pharmaceutical purposes for the treatment of human illnessesanti-tumor treatment; chemical reagents for medical purposes for the treatment of human illnesses; chemico-pharmaceutical preparations for treatment of human illnessesanti-tumor treatment; chewing gum for medical purposes; Chinese medicine nostrum for the treatment of tumors in humans; collyrium; contact lens cleaning preparations; contact lens disinfectant; contact lenses care solution; cough pastilles for pharmaceutical purposes; crystallized rock sugar for medical purposes; depuratives for the body; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical purposes; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; dietetic substances of low sugar and salt adapted for medical use; digestives for pharmaceutical purposes; drugs for medical purposes for treatment of human illnessesanti-tumor treatment; enzyme preparations for medical purposes; enzymes for medical purposes; esters for pharmaceutical purposes; ethers for pharmaceutical purposes; eye drops; filled portable medicine casescomprised of pharmaceuticals for treatment of human illnessesanti-tumor treatment; first-aid boxesfilled; fungicides; gelatine for medical purposesgelatin capsules sold empty; germicides; herbal teas for medicinal purposes; insect killing preparations in the nature of pesticides; insecticidal veterinary washes; insecticides; isotopes for medical purposes; media for bacteriological cultures; medical diagnosis reagent; medical probiotic supplements; medicated eye-washes; medicated lozenges for pharmaceutical purposes; medicinal drinks; medicinal hair growth preparations; medicinal preparations for the mouth to be applied in the form of capsules; medicines for alleviating constipation; medicines for dental purposes; mineralbath and sodium salts for medical purposes; ophthalmic pharmaceutical products for anti-tumor treatment; ophthalmic preparations; opotherapy preparations; organotherapy preparations; pesticides; petroleum jelly for medical purposes; pharmaceutical blood preparationsa blood clotting aid and delivery system for use in human medicine; pharmaceutical preparation for application to the eye or intraocular surgery for the purpose of anti-tumor treatment; pharmaceutical preparations for skin care; pharmaceutical preparations for treatment of human illnessesanti-tumor treatment; pharmaceutical preparationselixirs for anti-tumor treatment; phytotherapy preparations for medical purposes; pre-filled syringes of medicines for medical treatment purposesanti-tumor treatment; preparations for destroying noxious animals; protein dietary supplements; radioactive substances for medical purposes; radiological contrast substances for medical purposes; rat poison; raw material drugspharmaceuticals for anti-tumor treatment; reagent paper for medical purposes; reagent paper for veterinary purposes; rubbing alcohol; solutions for contact lenses; stem cells for medical purposes; sterilizing preparations; styptic preparations; tonics being pharmaceutical preparations for the treatment of human illnessesanti-tumor treatment; vaccine preparations; bacteriological preparations for veterinary use; cultures of microorganisms for veterinary use; chemical reagents for veterinary purposes; veterinary preparations for the treatment of intestinal bacteria; diagnostic preparations for veterinary use
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/06/2026
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
16/06/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/06/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/06/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
14/01/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
14/01/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
28/10/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
28/10/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/10/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/10/2024
ALIE
ASSIGNED TO LIE
02/10/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/06/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
15/03/2024
GNRT
NON-FINAL ACTION E-MAILED
15/03/2024
CNRT
SU - NON-FINAL ACTION - WRITTEN
15/03/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
29/02/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
29/02/2024
IUAF
USE AMENDMENT FILED
06/02/2024
EISU
TEAS STATEMENT OF USE RECEIVED
06/02/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
22/08/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
27/06/2023
PUBO
PUBLISHED FOR OPPOSITION
27/06/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/06/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
25/05/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/05/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/05/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/05/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
22/03/2023
GNRT
NON-FINAL ACTION E-MAILED
22/03/2023
CNRT
NON-FINAL ACTION WRITTEN
22/03/2023
DOCK
ASSIGNED TO EXAMINER
22/03/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
17/06/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16/06/2022
NWAP
NEW APPLICATION ENTERED
10/06/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ZEGFROVY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.